We found 11 single nucleotide polymorphisms and one triple nucleotide insertion in the cDNA of the human transforming growth factor (TGF-) III receptor gene (TGFBR3) located on 1p33-p32, encoding betaglycan, a component of the TGF-receptor system. Inside the 5Ј untranslated region (UTR), a GAEA polymorphism was identified at position 311. In the open reading frame (ORF), a non-conservative TAEC polymorphism was identified at position 392, and three conservative polymorphisms were found at positions 563 (GAEA), 1548 (GAEA), and 2370 (CAET). A triple nucleotide insertion (GCA) was identified at position 1419. Inside the 3Ј UTR, six polymorphisms were identified: four GAEA, at positions 2918, 3055, 3098, and 3355; one TAEA, at position 3183; and one GAEC, at position 3966. In addition to these changes, some divergences from the published sequence were observed in all 12 chromosomes tested. These included, in the ORF, an additional C after position 555, two additional G after position 563, and an additional T after position 1388. No T was found at position 1394. The alterations translate to a changed amino acid sequence. Inside the 3Ј UTR, additional discrepancies were identified. The discovered changes and polymorphisms may be useful for further genetic studies of TGFBR3 receptor deficiencies.
Introduction
Transforming growth factor-(TGF-) belongs to a family of multifunctional proteins which controls cell growth, differentiation, and morphogenesis in many different cell types (Roberts and Sporn 1990; Massagué 1990 ). Signal transduction is mediated through a receptor complex, consisting of TGF--receptors I and II (TGFBR1/TGFBR2), both containing a serine-threonine kinase domain, and the receptor-associated proteins betaglycan (TGFBR3) and endoglin (Lopez-Casillas et al. 1991; Buske et al. 1998) . The function of TGFBR3 is not fully clarified; however, evidence suggests that it supports the binding of TGF-to the TGFBR1-TGFBR2 complex, albeit that it lacks a recognizable signaling domain (Lopez-Cassilas et al. 1993) . Experimentally induced deficiency of TGFBR3 interfered with endocardial cell transformation in the heart, supporting its essential role in TGF-signaling (Brown et al. 1999) . In this report, we present 12 polymorphisms and some divergences from the published sequence found by sequencing the cDNA of TGFBR3 (n ϭ 6 Caucasian individuals), based on the known sequence of a 4208-bp fragment, consisting of an open reading frame (OFR) of 2547 bp (849 amino acids), flanked by a 5Ј untranslated region (UTR) of 348 bp and a 3Ј UTR of 1310 bp (Morén et al. 1992 ; GenBank accession no., L07594).
Materials and methods

RNA extraction
Total RNA was extracted from a lymphocyte and monocyte fraction of heparinized blood obtained after Ficoll sedimentation and homogenization, using a commercial kit (Qiagen, Hilden, Germany). Written informed consent was obtained from all subjects. The protocol was approved by the institutional ethics committee.
PCR conditions
cDNA was prepared in a Superscript One-Step-RT-PCRSystem (GIBCO BRL, Karlsruhe, Germany). About 150 ng of total RNA was incubated with 10 pmol of specific primers ( Genomic DNA (n ϭ 20 Caucasian individuals) was used for the examination of polymorphisms in two fragments, nt. 423 to 598 and 1504 to 1658. Primers utilized in this study are shown in Table 1 . The PCR was performed in a volume of 25 µl, containing 50 ng genomic DNA, 10mM Tris-HCl (pH 8,3), 1.5 mM MgCl 2 , 50 mM KCl, 250µM dNTPs, 25 pmol of each primer, and 1 unit of Taq polymerase. The PCR conditions were: initial denaturation at 95°C for 5 min, followed by 30 cycles of 94°C, 58°C, and 72°C, each for 1 min, with a final extension step of 7 min at 72°C.
The amplified PCR products were sequenced with the same primers on an Applied Biosystems (Foster City, CA, USA) automatic sequencer, using the dideoxy termination method.
Results
The cDNA of TGFBR3 was sequenced from six individuals in 11 fragments from positions 287 to 4208, i.e., the entire ORF, as well as 348 nucleotides of the 5Ј UTR and 1309 nucleotides of the 3Ј UTR.
A polymorphism in the 5Ј UTR At position 311, the most frequent nucleotide was G (four homozygotes and two heterozygotes) in contrast to the published sequence (A).
Polymorphisms in the ORF
The sequencing of the ORF was realized with eight overlapping cDNA fragments (Table 1) . At position 392, four individuals were homozygous and two were heterozygous for a TAEC transversion, translating to a deduced amino acid change of phenylalanine to serine at amino acid position 15 (Phe15Ser). A single nucleotide polymorphism was found at position 563 (one individual was homozygous and one heterozygous for a conservative GAEA transversion). All individuals had a guanine/cytosine/adenine insertion (1419GCA) after position 1419, translating to an additional alanine. It appears that these three bases were deleted in 20%-40% of the cDNA in all individuals. One individual showed an additional conservative homozygous 1548GAEA polymorphism. A further conservative mutation in the ORF was found at position 2370. Here we detected four homozygotes and two heterozygotes for a 2370CAET mutation.
Polymorphisms in the 3Ј UTR
The 3Ј UTR was sequenced in three overlapping fragments. One individual was heterozygous at positions 2918, 3055, and 3098 for a GAEA mutation and at position 3355 for a AAEG mutation. Five individuals were homozygous at position 3183 for a TAEA transversion. Moreover, at position 3966, five individuals were homozygous and one individual was heterozygous for a GAEC polymorphism.
Genomic sequence
The polymorphisms at positions 563 and 1548 were further analyzed in the genomic DNA of an additional 20 individuals (primers; see Table 1 ). At position 563, 13 individuals were homozygous for guanine, and 4 for adenine; 9 were heterozygous for this GAEA transversion (allele frequency of the G allele, 0.67 and of the A allele, 0.33). At position 1548, 12 individuals were homozygous for guanine and 4 for adenine; 10 were heterozygous for this GAEA transversion (allele frequency of the G allele, 0.65 and of the A allele, 0.35).
Divergences from the published sequence data Throughout the entire sequence, some divergences from the published sequence were observed in all six subjects tested ( Fig. 1) . In the ORF, divergences were detected after positions 555 (one additional cytosine) and 563 (two additional guanines). Compared with the published sequence, this results in the insertion of one single amino acid and translates to a changed amino acid sequence at positions 69/ 70/71 (AlaLeuArg to ArgThrAlaGly). Comparisons of the amino acid sequences in rat and pig TGFBR3 receptors (Morén et al. 1992 ) with the human amino acid sequence proposed herein showed conserved amino acids (pig: Arg/-/AlaAsp; rat: ArgSerThrAsp). After cytosine at position 1388, we observed an additional thymine in all individuals sequenced. By contrast, none of our sequences showed the thymine at position 1394. Compared with the published sequence, this translates to a changed amino acid sequence at positions 348/349, from IleVal to AsnArg). The amino acid sequences of the pig and rat showed, likewise, AsnArg at these positions. Inside the 3Ј UTR, we found no guanine at position 2909, and additional bases after position 2954 (guanine), after position 3586 (thymine), after position 3993 (cytosine), and after position 4060 (adenine). Discrepant bases were found at position 3424 (TAEA), at positions 3468 and 3469 (AAAETT), and at position 3525 (GAET).
Discussion
TGFBR3 is a proteoglycan that lacks significant intracellular signaling or enzymatic motifs, but may present the ligand to the TGFBR1/TGFBR2 signaling complex. Thus, the gene product may be essential for the high-affinity binding of TGF-2 (Lopez-Casillas 1994; Lin et al. 1995) . TGFBR3 may also facilitate TGF-binding to other receptors, stabilize multimeric receptor complexes, or segregate growth factor from activating receptors (Ji et al. 1999) . In testing genetic defects of the TGF-III receptor gene, the present characterization of 12 polymorphisms may be useful for further linkage or association studies on potentially related phenotypes, including developmental defects of the heart (Brown et al. 1999) . 
